OCUL · Company research

Ocular Therapeutix, Inc. (OCUL): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20267.23$1,722,010,836.341123369836.340———127.79301197328385903.3112982175251567—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.